carteolol has been researched along with Cerebrovascular Disorders in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasui, K | 1 |
| Ohmoto, T | 1 |
| Tamaki, T | 1 |
| Fukui, K | 1 |
| Iwao, H | 1 |
| Abe, Y | 1 |
1 other study available for carteolol and Cerebrovascular Disorders
| Article | Year |
|---|---|
Effects of prolonged treatment with beta-adrenoceptor antagonist, carteolol on systemic and regional hemodynamics in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Cardiac Output; Carteolol; Cerebrovascular Disorders; Hemodyna | 1991 |